Management Team

Avita-Management-images_AK

Adam Kelliher

CEO

Mr Kelliher has 20 years of healthcare industry experience as a successful entrepreneur with a strong marketing background and track record of creating and building life science companies. Adam was a global pioneer in the omega-3 space, founding Equateq Limited in 2006 as a cGMP-certified manufacturer of super-pure fatty acids for the nutritional, pharmaceutical and research sectors. Equateq was sold to BASF of Germany in 2012. Adam also started Equazen Limited in 2000, as a leading omega-3 and omega-6 supplement company. Equazen was sold to Galencia of Switzerland in December, 2007. New Zealand-born Adam had a previous career as a war correspondent, and holds degrees History and Politics.

Avita-Management-images_TR

Timothy Rooney

CFO

Mr Rooney has more then 20 years experience in senior finance and operations management, in both pharmaceutical wholesale distribution, and medical devices. Tim joined Avita Medical as CFO in 2012 and has also served the company as the Interim CEO from late 2013 to early 2015. Previously Mr. Rooney was an owner of PDI Enterprises, Inc., a pharmaceutical wholesale distributor, where he served as the CFO/COO. Mr. Rooney spearheaded and managed the growth of PDI from an early-stage regional operator to a market-leading company with national stage presence growing revenues from $5m to $430m. Mr. Rooney holds degrees in Finance and Economics.

Troy

Troy Barring

COO

Mr Barring has more than 20 years experience in implementing successful growth strategies for new products and building operational infrastructure. Troy has held a variety of senior leadership positions in both small and large companies in General Management, Sales & Marketing, R&D and Operations. Mr Barring has held leadership positions at Johnson & Johnson, Baxter Healthcare,  North American Scientific Medical, Boston Scientific, Orthozon Technologies, and InspiRD. Troy has an Executive MBA with an emphasis in Strategic Planning, and received his BS in Mechanical Engineering from the United States Military Academy, West Point.

Avita-Management-images_AQ

Andrew Quick

Senior VP Research & Technology

Mr Quick has 21 years experience in the medical device sector, and has particular expertise in design, development and clinical research. Prior to joining Avita in 2010, Andy headed US clinical research for investigational devices and post-market research for Advanced Bionics, LLC. Prior to that, Mr. Quick spent 10 years as VP of SonaMed Corporation, developing hearing screening and diagnostic devices. At Avita, Andy has implemented all aspects of its clinical strategy in several territories, and managed the FDA approval trial in burns. Mr. Quick holds degrees in Biomedical Engineering.

Avita-Management-images_JMc

Justin McCann

VP Finance

Mr McCann is a certified Management Accountant with over 20 years of finance experience in the tech and biotech sectors. Justin has extensive experience in several start-up and high-tech enterprises, including acquisitions, restructuring and change management. Prior to joining Avita, Mr McCann was Group Finance Manager and Company Secretary at NextGen Sciences and played a significant role in achieving an Initial Public Offering onto AIM, London. Mr McCann holds degrees in Biochemistry, Physiology and Marketing & International Trade.

Avita-Management-images_DF

David Fencil

VP Global Operations

Mr Fencil has 30 years medical device experience, in biomaterials, device design and development, operations, and quality systems.  David worked for 14 years at the Alfred Mann Foundation, a technology incubator in Valencia, CA, and related companies, where he managed development projects, quality system revisions and operational departments.  David came to Avita Medical in a product development role in 2012, and has managed the development of ReCell®  into the two further presentations:  ReGenerCell™ and ReNovaCell™.  Mr. Fencil holds degrees in Polymer Science and Business Administration.

Ross-Saunders Grey (2)

Ross Saunders

VP Sales & Marketing

Mr Saunders has 20 years medical device experience in international sales, global strategic marketing and general management. Ross was previously with Johnson & Johnson, where he held roles in the US, UK and Switzerland covering a variety of medical device businesses and surgical specialties. His sales background covers a range of territories, including 9 years spent managing international distributors. Ross also has significant experience in the development and marketing of disruptive technologies. He holds a BA (Honors) degree in European Business Administration & Languages from the Robert Gordon University, UK and a diploma from IEDN, Toulouse Business School, France.

Avita-Management-images_LG

Lorraine Glover

General Manager, Asia Pacific

Ms Glover has 22 years experience in the commercial biotechnology and medical devices industry. Lorraine has held various positions during this time, including research scientist, international sales manager, corporate and public/investor affairs, and manager regulatory, clinical and quality systems. Ms Glover joined in 2002 as Sales & Marketing Manager of Avita’s earlier incarnation, Visiomed. Lorraine holds degrees in Applied Sciences (Biology).

Avita-Management-images_CJ

Claire Johnson

General Manager, EMEA

Ms Johnson has more than 10 years experience in the medical device and regenerative medicine industry. Claire has extensive expertise in the acute and chronic woundcare markets, from both a clinical and commercial perspective, having held positions in Key Account Management, Clinical Management and Country Management. At Avita, Claire manages the European and Middle East export markets. Ms. Johnson holds a BSc (Honors) degree in Equine Science, and Chartered Institute of Personnel and Development qualification.

Garry Fleming

Garry Fleming

International Sales Director

Mr Fleming has over 40 years’ experience in the medical device industry in the sales and clinical areas. Garry was responsible in spearheading the growth of IntraVeno a medical device importer and distributor in Ireland from €.75 to 12.5 million in 11 years. Fleming was, uniquely, responsible for the introduction and success of the first, Integra® and second, Matriderm® DRTs [dermal regeneration templates] to the EMEA and global markets. Garry has held senior sales and clinical roles in; Dow Lepetit, Integra, Johnson& Johnson and MedSkin Solutions Dr Suwelack. He joined Avita in February ’16 after a number of months as a consultant for the company. He brings to Avita a global network of contacts in the field of burns, plastics and non-healing wounds.